114 related articles for article (PubMed ID: 26212266)
21. Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition.
Perego P; Cossa G; Tinelli S; Corna E; Carenini N; Gatti L; De Cesare M; Ciusani E; Zunino F; Luison E; Canevari S; Zaffaroni N; Beretta GL
Biochem Pharmacol; 2012 Jan; 83(1):27-36. PubMed ID: 21978643
[TBL] [Abstract][Full Text] [Related]
22. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.
Khomenko T; Zakharenko A; Odarchenko T; Arabshahi HJ; Sannikova V; Zakharova O; Korchagina D; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2016 Nov; 24(21):5573-5581. PubMed ID: 27658793
[TBL] [Abstract][Full Text] [Related]
23. Correlation between topoisomerase I and tyrosyl-DNA phosphodiesterase 1 activities in non-small cell lung cancer tissue.
Jakobsen AK; Lauridsen KL; Samuel EB; Proszek J; Knudsen BR; Hager H; Stougaard M
Exp Mol Pathol; 2015 Aug; 99(1):56-64. PubMed ID: 25987486
[TBL] [Abstract][Full Text] [Related]
24. Effects of DNA and protein size on substrate cleavage by human tyrosyl-DNA phosphodiesterase 1.
Interthal H; Champoux JJ
Biochem J; 2011 Jun; 436(3):559-66. PubMed ID: 21463258
[TBL] [Abstract][Full Text] [Related]
25. In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.
Soren BC; Babu Dasari J; Ottaviani A; Messina B; Andreotti G; Romeo A; Iacovelli F; Falconi M; Desideri A; Fiorani P
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299074
[TBL] [Abstract][Full Text] [Related]
26. [Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment].
Hu Z; Wang HW; An LK
Yao Xue Xue Bao; 2016 Feb; 51(2):215-25. PubMed ID: 29856574
[TBL] [Abstract][Full Text] [Related]
27. Studying TDP1 Function in DNA Repair.
Chiang SC; Liversidge K; El-Khamisy SF
Methods Mol Biol; 2018; 1703():173-181. PubMed ID: 29177742
[TBL] [Abstract][Full Text] [Related]
28. New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2).
Ribeiro CJA; Kankanala J; Shi K; Kurahashi K; Kiselev E; Ravji A; Pommier Y; Aihara H; Wang Z
Eur J Pharm Sci; 2018 Jun; 118():67-79. PubMed ID: 29574079
[TBL] [Abstract][Full Text] [Related]
29. Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.
Kiselev E; Ravji A; Kankanala J; Xie J; Wang Z; Pommier Y
DNA Repair (Amst); 2020 Jan; 85():102747. PubMed ID: 31775111
[TBL] [Abstract][Full Text] [Related]
30. A polysaccharide from Antrodia cinnamomea mycelia exerts antitumor activity through blocking of TOP1/TDP1-mediated DNA repair pathway.
Zhang Y; Wang Z; Li D; Zang W; Zhu H; Wu P; Mei Y; Liang Y
Int J Biol Macromol; 2018 Dec; 120(Pt B):1551-1560. PubMed ID: 30267816
[TBL] [Abstract][Full Text] [Related]
31. Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus.
Takagi M; Ueda JY; Hwang JH; Hashimoto J; Izumikawa M; Murakami H; Sekido Y; Shin-ya K
J Nat Prod; 2012 Apr; 75(4):764-7. PubMed ID: 22390627
[TBL] [Abstract][Full Text] [Related]
32. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
[TBL] [Abstract][Full Text] [Related]
33. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Fadeev DS; Komarova NI; Reynisson J; Arabshahi HJ; Chand R; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562592
[TBL] [Abstract][Full Text] [Related]
34. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
Liu C; Pouliot JJ; Nash HA
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14970-5. PubMed ID: 12397185
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.
Weidlich IE; Dexheimer T; Marchand C; Antony S; Pommier Y; Nicklaus MC
Bioorg Med Chem; 2010 Jan; 18(1):182-9. PubMed ID: 19963390
[TBL] [Abstract][Full Text] [Related]
36. Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft.
Kossmann BR; Abdelmalak M; Lopez S; Tender G; Yan C; Pommier Y; Marchand C; Ivanov I
Bioorg Med Chem Lett; 2016 Jul; 26(14):3232-3236. PubMed ID: 27262595
[TBL] [Abstract][Full Text] [Related]
37. Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB.
Ottaviani A; Iacovelli F; Fiorani P; Desideri A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923641
[TBL] [Abstract][Full Text] [Related]
38. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
Li D; Yuan Z; Chen S; Zhang C; Song L; Gao C; Chen Y; Tan C; Jiang Y
Bioorg Med Chem; 2017 Jul; 25(13):3437-3446. PubMed ID: 28511910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
